Helping families take charge of adenosine deaminase (ADA)-severe combined immunodeficiency (SCID)

Although rare, adenosine deaminase (ADA)-severe combined immunodeficiency (SCID) is one of the most serious primary immunodeficiency disorders. Children with ADA-SCID lack immune protection against bacteria, viruses, and fungi and are prone to repeated and persistent infections. Fortunately, effective treatments exist that can treat the disorder. Join the Immune Deficiency Foundation as we speak with Dr. Donald Kohn, Professor of Microbiology, Immunology & Molecular Genetics and Pediatrics at UCLA to answer your questions about this rare diagnosis and to explore the treatment options.